Evaluation of the army’s interim reference dose for GA

Journal of Toxicology and Environmental Health - Part A

Volumn 59, Issue 5-6, 2000, Pages 303-311

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28244466906     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/713852144     Document Type: Article

References (27)

1. Bonderman, R. P., and Bonderman, D. P. 1971. Atypical and inhibited human serum pseudocholinesterase. A titrimetric method for differentiation. Arch. Environ. Health 22:578-581.
2. Bucci, T. J., and Parker, R. M. 1992. Toxicity Studies on Agents GB and GD (Phase II): 90Day Subchronic Study of GB (Sarin, Type II) in CD Rats. Final Report. FDA 224-85-0007. DTIC AD-A248618. Prepared by the National Center for Toxicological Research, Jefferson, AR, for the U.S. Army Biomedical Research and Development Laboratory, Fort Detrick, Frederick, MD.
3. Bucci, T. J., Parker, R. M., Crowell, J. A., Thurman, J. D., and Gosnell, P. A. 1992. Toxicity Studies on Agent GA (Phase II): 90Day Subchronic Study of GA (Tabun) in CD Rats. Final Report. DTIC AD-A258042. Prepared by Pathology Associates, Inc., National Center for Toxicological Research, Jefferson, AR, for the U.S. Army Biomedical Research and Development Laboratory, Fort Detrick, Frederick, MD.
4. Cohen, E. M., Christen, P. J., and Mobach, E. 1971. The inactivation of oximes of sarin and soman in plasma from various species. I. The influence of diacetylmonoxime on the hydrolysis of sarin. Proc. Koninklijke Nederlandse Akad. Van Wetenschappen, Ser. C, Biol. Med. Sci. 74:113-131.
5. Denk, J. R. 1975. Effects of GB on Mammalian Germ Cells and Reproductive Parameters. EB-TR-74087. AD-A006503. Aberdeen Proving Ground, Edgewood, MD: Edgewood Arsenal.
6. Dulaney, M. D., Jr., Hoskins, B., and Ho, I. K. 1985. Studies on low dose sub-acute administration of soman, sarin and tabun in the rat. Acta Pharmacol. Toxicol. 57(4):234-241.
7. Ellin, R. I. 1981. Anomalies in theories and therapy of intoxication by potent organophosphorus anticholinesterase compounds. Special Publication U SA-BML-SP-81-003. DTIC AD-A101364. Aberdeen Proving Ground, Edgewood, MD: U.S. Army Medical Research and Development Command, Biomedical Laboratory.
8. Evans, F. T., G ray, P. W. S., Lehmann, H., and Silk, E. 1952. Sensitivity to succinylcholine in relation to seru m ch ol in es terase. Lancet i: 1129-1230.
9. Fonnum, F., and Sterri, S. H. 1981. Factors modifying the toxicity of organophosphorus compounds including soman and sarin. Fundam. Appl. Toxicol. 1:143-147.
10. Furlong, C. D., Li, W. F., Costa, L. G., Richter, R. J., Shih, D. M., and Lusis, A. J. 1998. Genetically determined susceptibility to organophosphate rus insecticides and nerve agents: Developing a mouse model for the human PON 1polymorphism. Neurotoxicology 19:645-650.
11. Goldman, M., Wilson, B. W., Kawakami, T. G., Rosenblatt, L. S., Culbertson, M. R., Schreider, J. P., Remsen, J. F., and Shifrine, M. 1988. Toxicity Studies on Agent VX. Final Report. DTIC AD-A201397. Prepared by the Laboratory for Energy-Related H ealth Research, U niversity of California, Davis, CA, for the U.S. Army Medical Research and Development Command, Fort Detrick, Frederick, MD.
12. Grob, D., and Harvey, J. C. 1958. Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate). J. Clin. Invest. 37:350-368.
13. Harris, H., and Whittaker, M. 1962. The serum chol inesterase variants. A study of twenty-two families selected via the "intermediate" phenotype. Ann. Hum. Genet. 26:59-72.
14. La Borde, J. B., and Bates, H. K. 1986. Developmental Toxicity Study of Agent GB — DCSM Types I and II in CD Rats and NZW Rabbits. Final Report. Prepared by the National Center for Toxico-logical Research, U.S. Food and Drug Administration, Jefferson, AR, for the U.S. Army Medical Research and Development Command, Fort Detrick, MD.
15. Loewenstein-Lichtenstein, Y., Schwarz, M., Glick, D., Norgaard-Pederson, B., Zakut, H., and Soreq, H. 1995. Genetic predisposition to adverse consequences of anti-cholinesterases in "atypical" BCHE carriers. Nat. Med. 1:1082-1085.
16. Maekawa, M., Sudo, K., Dey, D. C., Ishikawa, J., Izumi, M., Kotani, K., and Kanno, T. 1997. Genetic mutations of butyrylcholine esterase identified from phenotypic abnormalities in Japan. Clin. Chem. 43:924-929.
17. Morgan, D. P. 1989. Recognition and management of pesticide poisonings, 4th ed. EPA-540/9-88-001. Washington, DC: Health Effects Division, Office of Pesticide Programs, U.S. Environmental Protection Agency.
18. National Research Council. 1982. Possible long-term health effects of short-term exposure to chemical agents, Vol. 1. Anticholinesterases and anticholinergics. Washington, DC: National Academy Press.
19. National Research Council. 1984. Possible long-term health effects of short-term exposure to chemical agents, Vol. 2. Cholinesterase reactivators, psychochemicals, and irritants and vesicants. Washington, DC: National Academy Press.
20. National Research Council. 1985. Possible long-term health effects of short-term exposure to chemical agents, Vol. 3. Final Report. Current health status of test subjects. Washington, DC: National Academy Press.
21. Oak Ridge National Laboratory. 1996. Health Risk Assessment for the Nerve Agent GA. Draft Report. Interagency Agreement No. 1769-1769-A1. Prepared by Oak Ridge National Laboratory, Life Sciences Division, Oak Ridge, TN, for the U.S. Department of the Army, Army Environmental Center, Aberdeen Proving Ground, Edgewood, MD.
22. Registry of Toxic Effects of Chemical Substances. 1995. MEDLARS Online Information Retrieval System, National Library of Medicine, Bethesda, MD.
23. Traina, M. E., and Serpietri, L. A. 1984. Changes in the levels and forms of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate intoxication. Biochem. Pharmacol. 33:645-653.
24. U.S. Department of the Army. 1974. Chemical agent data sheets, Vol. 1. Edgewood Arsenal Special Report EO-SR 74001. Alexandria, VA: Defense Technical Information Center.
25. U.S. Environmental Protection Agency. 1989. Ethion Reference Dose for Chronic Oral Exposure. Integrated Risk Information System (IRIS). Online file, accessed 22 July 1998. http://www.epa. g ov/iris
26. U.S. Environmental Protection Agency. 1992. Malathion Reference Dose for Chronic Oral Exposure. Integrated Risk Information System (IRIS). Online file, accessed 22 July 1998. http://www.epa. g ov /iris
27. Weimer, J. T., McNamara, B. P., Owens, E. J., Cooper, J. G., and Van de Wal, A. 1979. Proposed Revision of Limits for Human Exposure to GB Vapor in Nonm ilitary Operations Based on One-Year Exposu res of Laboratory Animals to Low Air-borne Concentrations. ARCSL-TR-78056. Aberdeen Proving Ground, Edgewood, Md: U.S. Army Armament Research and Development Command, Chemical Systems Laboratory.